Arterio-Venous Malformations (AVMs) are congenital vascular defects 1 and are most commonly located in the head and neck area (81%). 2 The majority of these were localized over the cheek (31%) , ear(16%), nose (10%), forehead(10%), upper lip (7%), mandible (5%), neck (5%), and scalp and maxilla (4%).
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FEATURED GRAND ROUNDS
She was closely monitored through her 39th week of pregnancy when she delivered a healthy baby girl via caesarean section. No other complications or problems were encountered after and she was discharged on the eighth hospital day. We recommended excision of the AV malformation with reconstruction as a future treatment option.
DICUSSION
It has been estimated that the coexistence of pregnancy and AVM may result in a 150% increase in cardiac output above normal levels. 5 Several cases of high output cardiac failure have been reported in pregnancies related to AVM and beginning a pregnancy with a (arterio-venous malformation was considered). Magnetic resonance angiography (MRA) revealed a feeding vessel possibly from the external carotid artery. (Figure 3 ) Other examinations (2-D echocardiography and 12-lead ECG) were normal. Pure Tone Audiometry showed a moderately severe mixed hearing loss on the affected ear (left) and normal hearing on the contralateral side.
pre-existing AVM can be dangerous. Progesterone increases venous distensibility during pregnancy and the menstrual cycle and may explain the relationship of AVM and pregnancy. The risk of AVM bleeding is 2 to 3% per year although we have found no record of bleeding risks in AVM of the external ear in pregnancy. Thus, our patient was closely monitored and was co-managed with her obstetrician on out-patient care. 3, 4 Women with AVMs in pregnancy that were most likely to bleed tended to be younger (20-25 years) and were usually primiparous. Hemorrhages are most common between 15 and 20 weeks of gestation and could occur at any stage including during labour and in the puerperium. 4 There is really no conclusive data regarding AVM hemorrhage risk during pregnancy. According to Ogilvy et al., the incidence of hemorrhage in pregnancy in patients with a prior history of hemorrhage is 5.8% during the year after the last menstrual period, but the number of patients with hemorrhage was small which made the data nondefinitive. Neither of these rates was significantly different from similar nonpregnant populations. 4 Color doppler ultrasonography may be helpful in determining between high-and low-flow lesions in AVM. Magnetic resonance imaging (MRI) is said to be the diagnosis of choice since it depicts the extent and lack of invasion of these lesions providing multi-planar images and differentiating between high-and low-flow lesions. A Magnetic Resonance Angiogram (MRA) is the same non-invasive study but also examines the blood vessels as well as the structures of the brain, which is very advantageous as a guide if surgery is contemplated. 5 Options for definitive management of AVM include observation, corticosteroid therapy, surgery and interferon (INF) therapy. Because the vast majority of AVM are small, well circumscribed and involute with no sequelae and acceptable cosmetic results, observation remains the preferred management option. Other treatments include surgery, endovascular therapy and radiosurgery. The latter can be used alone or in combination to treat an AVM. Superselective arterial or retrograde venous embolization may also be used as first choice treatment for AVM not amenable to surgery. 3, 5 Aside from conservative observation, none of these are advisable in pregnant patients. 3, 5 Hemorrhage during delivery has been a major concern of obstetricians and patients. However, the available data would suggest that in most cases, vaginal delivery does not carry a higher risk for hemorrhage than delivery by cesarean section. There are no data available to address whether cesarean section helps to reduce the already low incidence of AVM-associated complications during delivery, although there is evidence that increased venous pressure during a Valsalva maneuver is not directly transmitted to the draining veins. 4 To our knowledge, there is no existing management guideline for AVM in the external ear area in pregnancy. Treatment should be individually planned to minimize further AVM enlargement and cardiovascular complications, utilizing conservative means rather than surgery as a primary option until after the pregnancy has been carried to term.
